We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Immunoassay Developed for Rapid Leptospirosis Diagnosis

By LabMedica International staff writers
Posted on 13 Nov 2012
A rapid assay has been developed using immunodominant Leptospira immunoglobulin-like proteins in a Dual Path Platform (DPP) for the diagnosis of leptospirosis.

The rapid point-of-care immunoassay was evaluated for accuracy in diagnostic performance and compared with the microscopic agglutination test (MAT), in an urban setting.

Scientists at Duke University School of Medicine (Durham, NC, USA) and their collaborators measured the sensitivity of the assay using 446 serum samples from 378 individuals with either mild or severe leptospirosis from two urban Brazilian populations. Control sera, including healthy blood donors, dengue cases, and patients with confirmed syphilis were also tested.

The DPP assay for leptospirosis was developed by Chembio Diagnostic Systems (Medford, NY, USA) and is manufactured by Bio-Manguinhos (Rio de Janeiro, Brazil). The sera assayed by the DPP were also tested by an immunoglobulin M enzyme-linked immunosorbent assay (IgM- ELISA) and the MAT. Three independent operators visually interpreted results of the DPP after 20 minutes as either positive or negative.

The overall sensitivity for paired sera was 100% for severe and 73% for mild disease. In the acute phase of the infection, the assay achieved a sensitivity of 85% for severe and 64% for mild leptospirosis. Within seven days of illness onset, the assay achieved a sensitivity of 77% for severe disease and 60% for mild leptospirosis. Sensitivity of the DPP assay was similar to that for IgM-ELISA and increased with both duration of symptoms.

The authors concluded that the DPP assay performed acceptably well for diagnosis of severe acute clinical leptospirosis and can be easily implemented in hospitals and health posts where leptospirosis is a major public health problem. However, test accuracy may need improvement for mild disease and early stage leptospirosis, particularly in regions with high transmission. The study was published on November 1, 2012, in the journal Public Library of Science Neglected Tropical Diseases (PLoSNTD).

Related Links:

Duke University School of Medicine
Chembio Diagnostic Systems
Bio-Manguinhos



Gold Member
Troponin T QC
Troponin T Quality Control
Automated Blood Typing System
IH-500 NEXT
New
Alpha-1-Antitrypsin ELISA
IDK alpha-1-Antitrypsin ELISA
New
Centrifuge
Centrifuge 5430/ 5430 R

Latest Microbiology News

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes

Innovative Diagnostic Approach for Bacterial Infections to Enable Faster and Effective Treatment